Roche Holding AG ADR News
Is This the First Alzheimer's Drug to Actually Work?
Biogen and Eisai announced a positive surprise for a closely-watched Alzheimer's drug candidate in a late-stage study.
Warren Buffett's Berkshire Makes List of Undervalued Stocks
Morningstar put together the roster, including only stocks receiving a moat from its analysts.
Regeneron's Eylea Win Leaves an Elephant in the Room
Regeneron's Eylea eye-disorder drug faces competitive pressure on multiple fronts. New data could cement its dominance.
Will the Stock Market Rebound Continue? Goldman Says ...
The stock market has rebounded from earlier declines lately, with the S&P 500 jumping 13% since June 16.
Can This Leading Drug Developer Stock Live Up to the Hype?
The drug developer aims to build novel maps of biology. What the heck does that mean, exactly?
Will uniQure Solve a Key Huntington's Disease Riddle?
Many companies are taking a similar approach, but no one is quite sure if it'll help patients.
The Sarepta Therapeutics Pipeline No One is Talking About
Gene therapy and gene editing get all the glory, but investors shouldn't overlook an emerging group of tools.
Trevor Noah Has Many Potential Replacements at 'The Daily Show'
But Comedy Central could also do something really unexpected with its former flagship program.
Musk Reveals New Cybertruck Features That Will Amaze EV Buyers
Tesla is expected to start production of its highly anticipated futuristic truck in 2023.
Disney Gives Beloved Character a Starring Movie Role
A development team led by Seth Rogen is working on a production that centers on a less well-known character with a nonetheless devoted following.
Fed Inflation Gauge Speeds Higher In August, Adding To Rate Hike Bets
The Fed's preferred inflation gauge topped Street forecasts Friday, snuffing out hopes of a near-term change in the central bank's rate hiking plans.